🔗 Permalink

Inventor profile of:

Wayne Marasco

City:

Wellesley, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2017-06-22

Top Assignees for applications by Wayne Marasco

The entities that hold a legal rights for patent applications filed by inventor Marasco Wayne:

Dana-Farber-Cancer Institute, Inc. 5 Boston, MA United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2 Boston, MA United States
The Brigham and Women's Hospital 1 Boston, MA United States
The Schepens Eye Research Institute Inc. 1 Boston, MA United States
Fox Chase Cancer Center 1 Jenkintown, PA United States
Burnham Institute for Medical Research 1 La Jolla, CA United States
Fox Chase Cancer Center 1 Philadelphia, PA United States
The Bingham and Women's Hospital 1 Boston, MA United States
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. 1 Louisville, KY United States

Recent patent applications by Marasco Wayne

Wayne Marasco from Wellesley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-06-22

US20170174751A1

Chemistry; metallurgy

IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES

#2 | 2017-02-16

US20170044262A1

Chemistry; metallurgy

Humanized monoclonal antibodies and methods of use

#3 | 2016-09-15

US20160263163A1

Human necessities

USES AND ISOLATION OF VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS

#4 | 2016-06-23

US20160176985A1

Chemistry; metallurgy

Humanized monoclonal antibodies and methods of use

#5 | 2016-01-28

US20160022743A1

Human necessities

HUMAN VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS FOR TREATMENT OF OCULAR DISEASE

#6 | 2014-11-20

US20140341863A1

Human necessities

ADULT MESENCHYMAL STEM CELL (MSC) COMPOSITIONS AND METHODS FOR PREPARING THE SAME

#7 | 2012-05-24

US20120128684A1

Chemistry; metallurgy

Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use

#8 | 2011-08-04

US20110189136A1

Human necessities

Uses and isolation of stem cells from bone marrow

#9 | 2011-07-14

US20110171210A1

Chemistry; metallurgy

Humanized monoclonal antibodies and methods of use

#10 | 2010-11-04

US20100278728A1

Chemistry; metallurgy

Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer

#11 | 2006-08-24

US20060188440A1

Chemistry; metallurgy

Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer

#12 | 2005-11-10

US20050249739A1

Chemistry; metallurgy

Antibodies against SARS-CoV and methods of use thereof

InventorID:

974937 ⎘